These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

705 related articles for article (PubMed ID: 8095303)

  • 1. X-ray structures of the antigen-binding domains from three variants of humanized anti-p185HER2 antibody 4D5 and comparison with molecular modeling.
    Eigenbrot C; Randal M; Presta L; Carter P; Kossiakoff AA
    J Mol Biol; 1993 Feb; 229(4):969-95. PubMed ID: 8095303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the three-dimensional structures of a humanized and a chimeric Fab of an anti-gamma-interferon antibody.
    Fan ZC; Shan L; Goldsteen BZ; Guddat LW; Thakur A; Landolfi NF; Co MS; Vasquez M; Queen C; Ramsland PA; Edmundson AB
    J Mol Recognit; 1999; 12(1):19-32. PubMed ID: 10398393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the mimicry of polysaccharide antigens by anti-idiotypic antibodies. The crystallization, molecular replacement, and refinement to 2.8 A resolution of an idiotope-anti-idiotope Fab complex and of the unliganded anti-idiotope Fab.
    Evans SV; Rose DR; To R; Young NM; Bundle DR
    J Mol Biol; 1994 Sep; 241(5):691-705. PubMed ID: 8071993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The de novo design of an antibody combining site. Crystallographic analysis of the VL domain confirms the structural model.
    Essen LO; Skerra A
    J Mol Biol; 1994 Apr; 238(2):226-44. PubMed ID: 8158652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X-ray structures of fragments from binding and nonbinding versions of a humanized anti-CD18 antibody: structural indications of the key role of VH residues 59 to 65.
    Eigenbrot C; Gonzalez T; Mayeda J; Carter P; Werther W; Hotaling T; Fox J; Kessler J
    Proteins; 1994 Jan; 18(1):49-62. PubMed ID: 7908437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local and transmitted conformational changes on complexation of an anti-sweetener Fab.
    Guddat LW; Shan L; Anchin JM; Linthicum DS; Edmundson AB
    J Mol Biol; 1994 Feb; 236(1):247-74. PubMed ID: 7893280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural consequences of humanizing an antibody.
    Holmes MA; Foote J
    J Immunol; 1997 Mar; 158(5):2192-201. PubMed ID: 9036965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
    Wu H; Nie Y; Huse WD; Watkins JD
    J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Energy-based analysis and prediction of the orientation between light- and heavy-chain antibody variable domains.
    Narayanan A; Sellers BD; Jacobson MP
    J Mol Biol; 2009 May; 388(5):941-53. PubMed ID: 19324053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular modeling of cardiac glycoside binding by the human sequence monoclonal antibody 1B3.
    Paula S; Monson N; Ball WJ
    Proteins; 2005 Aug; 60(3):382-91. PubMed ID: 15971203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformations of the third hypervariable region in the VH domain of immunoglobulins.
    Morea V; Tramontano A; Rustici M; Chothia C; Lesk AM
    J Mol Biol; 1998 Jan; 275(2):269-94. PubMed ID: 9466909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humanization by variable domain resurfacing and grafting on a human IgG4, using a new approach for determination of non-human like surface accessible framework residues based on homology modelling of variable domains.
    Staelens S; Desmet J; Ngo TH; Vauterin S; Pareyn I; Barbeaux P; Van Rompaey I; Stassen JM; Deckmyn H; Vanhoorelbeke K
    Mol Immunol; 2006 Mar; 43(8):1243-57. PubMed ID: 16118019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection, characterization and x-ray structure of anti-ampicillin single-chain Fv fragments from phage-displayed murine antibody libraries.
    Burmester J; Spinelli S; Pugliese L; Krebber A; Honegger A; Jung S; Schimmele B; Cambillau C; Plückthun A
    J Mol Biol; 2001 Jun; 309(3):671-85. PubMed ID: 11397088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rational construction of an antibody against cystatin: lessons from the crystal structure of an artificial Fab fragment.
    Schiweck W; Skerra A
    J Mol Biol; 1997 May; 268(5):934-51. PubMed ID: 9180382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional structures of the Fab fragment of murine N1G9 antibody from the primary immune response and of its complex with (4-hydroxy-3-nitrophenyl)acetate.
    Mizutani R; Miura K; Nakayama T; Shimada I; Arata Y; Satow Y
    J Mol Biol; 1995 Nov; 254(2):208-22. PubMed ID: 7490744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of an antigen-binding fragment bound to single-stranded DNA.
    Tanner JJ; Komissarov AA; Deutscher SL
    J Mol Biol; 2001 Dec; 314(4):807-22. PubMed ID: 11733999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for the binding of an anti-cytochrome c antibody to its antigen: crystal structures of FabE8-cytochrome c complex to 1.8 A resolution and FabE8 to 2.26 A resolution.
    Mylvaganam SE; Paterson Y; Getzoff ED
    J Mol Biol; 1998 Aug; 281(2):301-22. PubMed ID: 9698550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The three-dimensional structure of a complex of a murine Fab (NC10. 14) with a potent sweetener (NC174): an illustration of structural diversity in antigen recognition by immunoglobulins.
    Guddat LW; Shan L; Broomell C; Ramsland PA; Fan Z; Anchin JM; Linthicum DS; Edmundson AB
    J Mol Biol; 2000 Sep; 302(4):853-72. PubMed ID: 10993728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of an Fab fragment in complex with a meningococcal serosubtype antigen and a protein G domain.
    Derrick JP; Maiden MC; Feavers IM
    J Mol Biol; 1999 Oct; 293(1):81-91. PubMed ID: 10512717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-dimensional structures of a humanized anti-IFN-gamma Fab (HuZAF) in two crystal forms.
    Bourne PC; Terzyan SS; Cloud G; Landolfi NF; Vásquez M; Edmundson AB
    Acta Crystallogr D Biol Crystallogr; 2004 Oct; 60(Pt 10):1761-9. PubMed ID: 15388922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.